Premenstrual syndrome, premenstrual dysphoric disorder, and coping strategies in women with menstrual migraine - Takeaways - MDSpire

Premenstrual syndrome, premenstrual dysphoric disorder, and coping strategies in women with menstrual migraine

  • By

  • Alshimaa S. Othman

  • Mona Hussein

  • Alaa Elmazny

  • Salsabil Abo Al-Azayem

  • Azza Elashiry

  • Mennat-Allah Tarek

  • Heba Qassim Shamardal

  • Sara El-Sayed Abd El-Ghani

  • Mohamed Wagdy

  • Eman Hany Elsebaie

  • Doaa Lotfy Abd El Baky

  • Rehab Magdy

  • May 29, 2026

  • 0 min

Share

  • 1

    Women with menstrual migraine (MM) reported significantly higher premenstrual symptoms and headache impact compared to those without MM.

  • 2

    The study confirmed PMDD in 5.6% of women with MM, indicating a potential link between PMDD and increased headache severity.

  • 3

    Higher scores on the Premenstrual Symptoms Screening Tool (PSST) were associated with greater headache burden as measured by the Headache Impact Test-6 (HIT-6).

  • 4

    Lower utilization of awareness and acceptance coping strategies correlated with increased headache severity among women with MM.

  • 5

    The findings highlight the importance of effective coping strategies in managing PMS and headache severity in women with menstrual migraine.

Original Source(s)

Premenstrual syndrome, premenstrual dysphoric disorder, and coping strategies in women with menstrual migraine

  • by Alshimaa S. Othman, Mona Hussein, Alaa Elmazny, Salsabil Abo Al-Azayem, Azza Elashiry, Mennat-Allah Tarek, Heba Qassim Shamardal, Sara El-Sayed Abd El-Ghani, Mohamed Wagdy, Eman Hany Elsebaie, Doaa Lotfy Abd El Baky, Rehab Magdy

  • May 29, 2026

Related Content

Three-year real-world effectiveness, treatment persistence, and planned discontinuation of anti-calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a single-center cohort from Japan

Activation and sensitization of meningeal nociceptors by PACAP-38: implications for migraine headache

Zack Z. Ramilevich, M.D., Joins Marcus Neuroscience Institute as a General Neurologist

Board-certified neurologist Zack Z. Ramilevich, M.D., has joined Marcus Neuroscience Institute, part of Baptist Health, as a general neurologist.

  • by

  • March 26, 2026

  • 2 min